A double-blind controlled evaluation of Diproderm cream 0.05%, twice a day treatment in comparison with once a day treatment in eczema.
A double-blind study, carried out at two centres, comparing once and twice a day application of betamethasone-17,21-dipropionate cream 0.05% (Diproderm), has shown that the efficacy in treating eczema is the same after 1 week.
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004485:Eczema / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D009824:Ointments
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone